News

LSOMS Holdings Completes First Acquisition, Strengthening Compliance & Lab Validation Service Offerings for Life Sciences Firms

June 17, 2025

3 Boomerang Portfolio Company Acquires Pinnaql as First Step to Scale Best-in-Class Consulting Platform for Guiding Clients Through Complex Regulatory Environments

Learn more

3 Boomerang Capital Makes Investment to Foster Strategic Growth at Matrix Plastic Products

June 10, 2025

3BC's Funding & Support Fuels Company's Growth While Scaling and Optimizing Production of Key Components to Medical Device Manufacturers

Learn more

3 Boomerang Capital Forms LSOMS Holdings, L.P., a Quality & Regulatory Consulting Platform Led by Life Sciences Veteran John Duffin

June 3, 2025

3 Boomerang Capital, LP ("3BC"), a healthcare-focused, lower-middle-market private equity firm, today announced the launch of LSOMS Holdings, L.P.

Learn more

3 Boomerang Capital Announces Strategic Growth Investment in Bio-Response Solutions

March 25, 2025

Leading Provider of Regulated Biomedical Waste Solutions, Designed to Be Energy-Efficient & Environmentally Responsible, Receives Strategic Resources & Capital to Continue Rapid Growth

Learn more

3 Boomerang Capital Appoints Martin LeBlanc as Chairman of Strategic & Operational Advisory Board

January 23, 2025

3 Boomerang Capital ("3BC" or "3 Boomerang"), a healthcare-focused private equity firm committed to driving transformative growth for lower middle-market businesses, is proud to announce the appointment of Martin LeBlanc as chairman of its Strategic & Operational Advisory Board.

Learn more

Enjoin, LLC Appoints Healthcare Innovator Steve Hynes as Executive Chairman of its Board

December 5, 2024

Enjoin, LLC ("Enjoin" or the "Company") is pleased to announce that experienced healthcare leader Steve Hynes has joined its Board of Directors (the "Board") as executive chairman.

Learn more

3 Boomerang Capital Announces Growth Recapitalization of Enjoin, LLC

November 21, 2024

3 Boomerang Capital ("3BC" or "3 Boomerang"), a healthcare-focused, lower middle-market private equity firm, announces a majority growth investment in Enjoin, LLC ("Enjoin" or the "Company"), a leader in Clinical Documentation Integrity ("CDI") solutions for hospitals and health systems nationwide.

Learn more

3 Boomerang Capital Announces Strategic Growth Investment in Analytical Biological Services Inc.

June 24, 2024

3 Boomerang Capital has announced a strategic growth investment in Analytical Biological Services Inc. (ABS), marking the first platform investment of its newly closed Fund I.

Learn more

3 Boomerang Capital Closes Flagship Private Equity Fund Above Target

February 6, 2024

3 Boomerang Capital Raises Over $375 Million for Healthcare Private Equity Fund, Exceeding Target

Learn more